WHY OCTOBER 22 IS AN IMPORTANT DAY FOR CORONAVIRUS VACCINES? DETAILS

Home > News Shots > India

By Saradha | Aug 21, 2020 01:22 PM

The US Food and Drug Administration is planning to conduct an advisory panel meeting on October 22 to discuss the progress of various COVID-19 vaccines. The meeting is important since large- scale clinical trials are likely to be held by Moderna Inc, Pfizer Inc and AstraZeneca Plc. 

US health regulator meet on oct22 to discuss covid vaccine development

A top US health regulator who will be among the panel that decides the fate of coronavirus vaccines told media that the trials were enrolling a good number of volunteers and it was “possible” that data could be available to interpret by October. Otherwise the committee will be discussing regulatory issues regarding the vaccine production. 

Pfizer Inc and BioNTech SE said that they are developing a COVID19 vaccine jointly and they have submitted it for regulatory review.  The companies revealed that only 20% of volunteers how took the vaccine have developed side effects such as mild to moderate fever. The companies will continue to analyze data from Phase 1 trials that were held in U.S and Germany.

 

“In the US, the race to produce a vaccine has become the centerpiece of his Trump administration's response. The US government has invested nearly $11 billion to help develop and manufacture more than half a dozen coronavirus vaccine candidates,” Livemint reported.

அரசியல், விளையாட்டு, நாட்டுநடப்பு, குற்ற சம்பவங்கள், வர்த்தகம், தொழில்நுட்பம், சினிமா, வாழ்க்கை முறை என பலதரப்பட்ட சுவாரஸ்யமான செய்திகளை தமிழில் படிக்க இங்கு கிளிக் செய்யவும்      

RELATED NEWS STORIES

ABOUT THIS PAGE

This page contains news relating to various facts and events. The views are generally about current affiars and general topics in diversified areas such as political, international, national, and regional issues, sports, health, travel, lifestyle, technology and business. People having similar interets on the above topics will find this page useful. US health regulator meet on oct22 to discuss covid vaccine development | India News.